Table 1.
Baseline demographic and tumor characteristics of our patient cohort who received IORT (N = 167)
| Baseline characteristics | N (%) |
|---|---|
| Age, median (range), yrs | 66 (49–89) |
| 45–49 yrs | 1 (0.6%) |
| 50–59 yrs | 40 (24%) |
| 60–69 yrs | 76 (45.5%) |
| 70–74 yrs | 35 (21%) |
| >74 yrs | 15 (9%) |
| Ethnicity | |
| Hispanic or Latino | 65 (38.9%) |
| Not Hispanic or Latino | 76 (45.5%) |
| N/A | 26 (15.6%) |
| Race | |
| Black or African American | 41 (24.6%) |
| White | 39 (23.4%) |
| Asian | 3 (1.8%) |
| Other Pacific Islander | 1 (0.6%) |
| Other | 63 (37.7%) |
| N/A | 20 (12%) |
| Initial Pathology per lesion (N = 172) | |
| Invasive ductal carcinoma | 120 (69.8%) |
| Invasive lobular carcinoma | 9 (5.2%) |
| Ductal carcinoma in-situ | 39 (22.7%) |
| Other | 4 (2.3%) |
| Receptor status per lesion (N = 172) | |
| ER positive | 172 (100%) |
| PR positive | 154 (89.5%) |
| Her-2/neu positive | 6 (3.5%) |
| Clinical tumor size, median (range), mm | 10 (1–40) |
| Clinical Stage per lesion (N = 172) | |
| 0 | 40 (23.3%) |
| IA | 118 (68.6%) |
| IB | 5 (2.9%) |
| IIA | 9 (5.2%) |
| Depth from nipple, median (range), cm | 6 (1–19) |
| BMI, median (range), kg/m2 | 29.3 (19.3–60.8) |